Jointly provided by

   
This activity is supported by educational grants from Shire, CSL Behring, and Novo Nordisk, Inc.


Click here to download the slides from this webcast.

Check back in 2019 for an on-demand CE activity based on these webcasts!


ManagedCareHemo.com Presents:
Hemophilia Care Coordination and Current Treatment Options: The Latest Insights for Managed Care and Specialty Pharmacy
Track 1: Treatment Recommendations and Practice Guidelines Update
Track 2: Application of Enhanced Care Coordination

LIVE WEBCAST DATES


TRACK DAY DATE TIME
Track 1 Wednesday July 11, 2018 1:30 PM - 3:00 PM ET
Track 2 Thursday July 26, 2018 1:30 PM - 3:00 PM ET
Track 1 Wednesday October 17, 2018 1:30 PM - 3:00 PM ET
Track 2 Tuesday October 2, 2018 12:30 PM - 2:00 PM ET


TARGET AUDIENCE
  • Medical Directors and Pharmacy Directors from health plans, HMOs, integrated health systems, employers, quality organizations, and other managed care organizations (MCOs)
  • Managed care-affiliated care team members involved with patient evaluation, education, and follow-up for hemophilia patients including: physicians, pharmacists, specialty pharmacists, and nurses
 
PROGRAM OVERVIEW
The management of hemophilia is complex; however, appropriate management is vital to minimizing and/or preventing complications that can contribute to poor health outcomes and higher health care resource utilization. Thus, there is a need for continued education in several key areas involving the effective management of patients with hemophilia in a managed care setting. They emphasize the need for a well-coordinated patient management effort, the importance of understanding the most cost-effective ways of using available treatments, and importance of collaboration among all stakeholders, which includes leveraging the success of the comprehensive care model utilized by HTCs. This educational initiative is designed to address these needs in order to improve clinical, economic, and humanistic outcomes for patients with hemophilia.

EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to:
  • Describe recent insights into the safety, efficacy and attributes of recently approved and emerging hemophilia treatment options.
  • Review alignment of recently approved therapies in the current hemophilia treatment algorithm.
  • Explain hemophilia-related complications associated with inhibitor development and its significant clinical and economic consequences.
  • Apply processes for managed care organizations and specialty pharmacy providers to improve communications and collaborations with HTCs.
LEARNING GOAL/PURPOSE
This educational initiative is designed to improve managed care professionals' knowledge and competence in the management of pediatric and adult hemophilia patients in health plan, specialty pharmacy, and other types of managed care settings.

DISTINGUISHED MULTI-DISCIPLINARY FACULTY PRESENTERS:
Hemophilia Clinical Experts Managed Care Experts Specialty Pharmacy Experts
Shannon Carpenter, MD, MS
Professor of Pediatrics, UMKC School of Medicine Hematology/Oncology, Director Kansas City Regional Hemophilia Treatment Center
Director, Anticoagulation Management Program
Children's Mercy Hospital

Mark T. Reding, MD
Associate Professor of Medicine
Director, Center for Bleeding and Clotting Disorders
University of Minnesota Medical Center
John Fox, MD, MHA
Vice President, Associate Chief Medical Officer
Medical Affairs
Priority Health

James Kenney, Jr., RPh, MBA
Manager, Specialty and Pharmacy Contracts
Harvard Pilgrim Health Care
Jay Bryant-Wimp, RPh
Owner/CEO
Accurate Rx Pharmacy
WEBCAST AGENDAS
Track 1: Treatment Recommendations and Practice Guidelines Update
Presentation Faculty
Introduction Moderator
Clinical Strategies for Prophylaxis and Inhibitor Management Mark T. Reding, MD
Alignment of Therapies within the Current Treatment Algorithm James Kenney, Jr., RPh, MBA
Faculty Idea Exchange / Managed Care Case Studies All
Audience Question and Answer Session, Key Takeaways, and Closing Comments All


Track 2: Application of Enhanced Care Coordination
Presentation Faculty
Introduction Moderator
Communication and Collaboration Recommendations for Optimal Outcomes Shannon Carpenter, MD, MS
Methods to Enhance Patient Adherence Jay Bryant-Wimp, RPh
Cost Management Strategies for Clotting Factor Replacement Therapy John Fox, MD, MHA
Faculty Idea Exchange / Managed Care Case Studies All
Audience Question and Answer Session, Key Takeaways, and Closing Comments All


ACCREDITATION STATEMENTS

Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Education Resources, Inc. (MER), National Hemophilia Foundation, and Impact Education, LLC. MER is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Medical Education Resources, Inc. designates these live activities for a maximum of 1.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • Track 1: Treatment Recommendations and Practice Guidelines Update -1.5 CME Credits
  • Track 2: Application of Enhanced Care Coordination -1.5 CME Credits

Pharmacy Credit
Medical Education Resources, Inc. (MER) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MER designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
  • Track 1: Treatment Recommendations and Practice Guidelines Update - 1.5 contact hours, UAN: 0816-9999-18-135-L01-P
  • Track 2: Application of Enhanced Care Coordination - 1.5 contact hours, UAN: 0816-9999-18-136-L01-P
This activity is certified as Knowledge-based CPE.

Nursing Credit
Medical Education Resources, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This CE activity provides 1.5 contact hours of continuing nursing education.
Medical Education Resources, Inc. is accredited as a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, and certifies this activity for 1.5 contact hours.
  • Track 1: Treatment Recommendations and Practice Guidelines Update - 1.5 contact hours
  • Track 2: Application of Enhanced Care Coordination - 1.5 contact hours

Disclosure of Conflicts of Interest
It is the policy of Medical Education Resources, Inc. to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.

Hardware/Software Requirements
Compatible with Internet Explorer 6 and up, Mozilla Firefox 3 and up, Safari 4.0, and Google Chrome 10 and up

Fee Information
There is no fee for this educational activity.

If you have any questions, please call (215) 619-8812 or email info@impactedu.net.